SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-063374
Filing Date
2022-05-20
Accepted
2022-05-20 16:06:29
Documents
12
Period of Report
2022-05-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2216208d1_8k.htm   iXBRL 8-K 33239
  Complete submission text file 0001104659-22-063374.txt   205964

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA swtx-20220519.xsd EX-101.SCH 3204
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE swtx-20220519_lab.xml EX-101.LAB 34594
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE swtx-20220519_pre.xml EX-101.PRE 22723
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2216208d1_8k_htm.xml XML 3501
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 22947605
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences